CACNA1D and prostate cancer: A bioinformatics meta-analysis of the Oncomine dataset (Wang et al. [95]) revealed that various subtypes of VGCCs (CACNA1D or Cav1.3 included) were implicated in the development and progression of diverse types of cancer, including cancer of the prostate, breast, colorectum, bladder, stomach, lung, brain, uterus and esophagus [95].